Chiral Chemicals Market to Hit USD 206.0 Billion by 2035 | BASF SE, Johnson Matthey, Codexis Inc. Lead - Fact.MR

The global chiral chemicals market is projected to reach USD 206.0 billion by 2035, up from USD 73.2 billion in 2025. The industry is expected to progress at a CAGR of 10.9%, This growth is fueled by increasing demand for enantiomerically pure compounds in pharmaceuticals, agrochemicals, and other high-value applications, alongside a global shift toward sustainable and green chemistry practices. The market's expansion is particularly pronounced in regions like Asia-Pacific, driven by pharmaceutical and agrochemical production hubs in China, India, and Japan, while North America and Europe also play critical roles due to their advanced R&D and stringent regulatory frameworks. Despite challenges such as high production costs and complex regulations, the chiral chemicals market is set to thrive, supported by technological advancements and rising consumer demand for eco-friendly and high-efficacy products. Key players like BASF SE, Johnson Matthey, and Codexis Inc. are at the forefront, leveraging innovation and strategic partnerships to maintain their competitive edge.

Browse for A Report: https://www.factmr.com/report/5397/chiral-chemicals-market

Chiral Chemicals Market Technology Development:

Technological advancements are reshaping the chiral chemicals industry, with a strong emphasis on sustainability and efficiency. Asymmetric hydrogenation, which holds the largest revenue share in 2025, is a cornerstone technology due to its ability to produce high-purity enantiomers with excellent yield and selectivity. This method is particularly critical in pharmaceutical synthesis, where precision is paramount. Meanwhile, biocatalysis is emerging as the fastest-growing segment, driven by its alignment with green chemistry principles. Biocatalytic methods, utilizing enzymes or microorganisms, offer high enantioselectivity under mild conditions, reducing energy consumption and waste. Recent developments, such as Kaneka Corporation's launch of immobilized enzymes in November 2024, highlight the industry's focus on enhancing efficiency and sustainability. Additionally, advancements in chiral pool and resolution methods are improving scalability and cost-effectiveness, enabling broader adoption across industries. These innovations not only meet regulatory demands from bodies like the EPA and EU REACH but also cater to the growing preference for environmentally friendly production processes, positioning the chiral chemicals market for long-term growth.

Chiral Chemicals Market Demand and Impact Analysis:

The demand for chiral chemicals is primarily driven by the pharmaceutical industry, where single-enantiomer drugs are increasingly favored for their superior efficacy and safety profiles. With most newly developed drugs being chiral, the need for enantiomerically pure active pharmaceutical ingredients (APIs) is surging, particularly for treatments targeting cardiovascular diseases, neurological disorders, and metabolic syndromes. The agrochemical sector also significantly contributes to demand, as chiral pesticides and herbicides offer higher selectivity and reduced environmental impact compared to racemic mixtures. This aligns with regulatory pressures from agencies like the EPA and EU REACH, which advocate for sustainable chemical practices. Additionally, the growing adoption of chiral compounds in flavors and fragrances, driven by consumer demand for natural and complex scent profiles, is boosting market growth. However, challenges such as high production costs, complex regulatory approvals, and technological limitations in scalable synthesis methods could restrain market expansion. The shift toward green chemistry, exemplified by increased use of biocatalysis and asymmetric hydrogenation, creates opportunities for manufacturers to innovate and meet evolving market and regulatory demands.

Chiral Chemicals Market Analysis by Top Investment Segments:

The chiral chemicals market is segmented by technology (asymmetric hydrogenation, biocatalysis, chiral pool, resolution methods), application (pharmaceuticals, agrochemicals, flavors & fragrances, specialty chemicals), and end-user (pharmaceutical companies, agrochemical companies, food & beverage industry, research & academic institutes). The pharmaceutical application segment dominates, accounting for the largest revenue share in 2025 due to the critical role of chiral intermediates in drug development. This segment is expected to maintain its lead, driven by regulatory requirements for enantiomerically pure APIs and the rising prevalence of chronic diseases. The flavors and fragrances segment is the fastest-growing, fueled by consumer demand for natural and complex profiles in personal care and food products. By technology, asymmetric hydrogenation leads due to its scalability and efficiency, while biocatalysis is gaining traction for its sustainability benefits. Pharmaceutical companies represent the largest end-user segment, driven by heavy R&D investments and the shift toward targeted therapies. The food and beverage industry is emerging as a high-growth segment, propelled by innovations in food chemistry and expanding global consumer markets. These segments present significant investment opportunities, particularly in regions with robust pharmaceutical and agrochemical industries.

Chiral Chemicals Market Across Top Countries:

The chiral chemicals market exhibits distinct regional dynamics, with key countries driving growth:

-China: Leading the global market, China's growth is propelled by its expansive pharmaceutical and agrochemical sectors. With a projected CAGR of 12.2% from 2025 to 2035, initiatives like Made in China 2025 are fostering advancements in biotechnology and specialty chemicals, reducing import dependency and boosting domestic production of chiral APIs.
-United States: A major market, the U.S. benefits from its leadership in pharmaceutical R&D and biotechnology. The FDA's emphasis on chirally pure drugs drives demand, while the agrochemical sector's adoption of chiral pesticides supports sustainable practices. The U.S. market is expected to grow steadily, fueled by innovation in asymmetric synthesis and precision medicine.
-Germany: A key player in Europe, Germany's market is driven by its advanced chemical and pharmaceutical industries. The country's focus on green chemistry and compliance with EU regulations promotes the adoption of chiral synthesis. Collaborations between academia and industry further strengthen its position.
-India: With a rapidly growing pharmaceutical and agrochemical sector, India is a high-growth market. Large-scale manufacturing capacities and competitive labor costs drive demand for chiral chemicals, particularly in API production.
Japan: Japan's market benefits from government support for biotechnology and green manufacturing. The country's focus on high-quality chiral compounds for pharmaceuticals and agrochemicals positions it as a significant contributor to regional growth.
-Asia-Pacific leads globally due to its manufacturing hubs, while North America and Europe follow, driven by R&D and regulatory support for sustainable practices.

Leading Chiral Chemicals Companies and Their Industry Share:

The chiral chemicals market is highly competitive, with key players like BASF SE, Johnson Matthey, Codexis Inc., Solvias AG, Kaneka Corporation, Lonza Group AG, and Daicel Corporation dominating. These companies leverage advanced technologies, robust supply chains, and strong patent portfolios to maintain their market positions. BASF SE, for instance, announced plans in April 2025 to expand its asymmetric hydrogenation catalyst production in Germany, targeting pharmaceutical demand. Codexis Inc.'s March 2025 partnership with a European pharmaceutical company underscores its focus on biocatalysis for chiral API production. Kaneka Corporation's immobilized enzyme launch in November 2024 highlights its commitment to sustainable production. These players differentiate through R&D investments, custom synthesis services, and geographic expansion via mergers, acquisitions, and joint ventures. Their ability to offer tailored solutions and comply with stringent regulations strengthens their market share, particularly in pharmaceuticals and agrochemicals, while smaller regional players contribute to market fragmentation in emerging economies.

Chiral Chemicals Market Historic and Future Pathway Analysis:

From 2020 to 2024, the chiral chemicals market grew at a CAGR of 7.7%, driven by increasing demand for single-enantiomer drugs and eco-friendly agrochemicals. The market size rose from a lower base to USD 73.2 billion in 2025, reflecting growing adoption of chiral synthesis technologies. Looking ahead, the market is projected to grow at a CAGR of 10.9% through 2035, reaching USD 206.0 billion. This growth will be driven by continued pharmaceutical innovation, regulatory support for sustainable practices, and rising demand in emerging markets. The shift toward biocatalysis and other green technologies will be a key trend, aligning with global sustainability goals. Challenges such as high production costs and regulatory complexities will require companies to invest in cost-effective and scalable solutions. Emerging economies, particularly in Asia-Pacific, will drive demand due to rapid industrialization and healthcare advancements, while North America and Europe will remain critical for high-value R&D and innovation.

Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=5397

Chiral Chemicals Industry News:

-Recent developments underscore the dynamic nature of the chiral chemicals market. In April 2025, BASF SE announced capacity expansion for asymmetric hydrogenation catalysts in Germany, targeting pharmaceutical applications. Codexis Inc.'s

-March 2025 partnership with a European pharmaceutical firm focuses on developing novel biocatalysts for chiral API production.

-In November 2024, Kaneka Corporation introduced immobilized enzymes to enhance biocatalytic efficiency, aligning with sustainability trends. These initiatives reflect the industry's focus on innovation, scalability, and environmental compliance. Additionally, increasing M&A activity and geographic expansion, particularly in Asia-Pacific and North America, are creating new growth opportunities. The rise of green chemistry and regulatory support for eco-friendly compounds are driving companies to invest in R&D and strategic collaborations, ensuring the market's alignment with global sustainability and performance demands.

Explore More Related Studies Published by Fact.MR Research:

Ammonium Bromide Market : https://www.factmr.com/report/ammonium-bromide-market
Automotive Steering Shaft Market : https://www.factmr.com/report/automotive-steering-shaft-market
Metallurgical Microscope Market : https://www.factmr.com/report/metallurgical-microscope-market
Multi Spindle Machines Market : https://www.factmr.com/report/multi-spindle-machines-market
Liquid Propellants Market: https://www.factmr.com/report/Liquid-Propellants-Market
Depyrogenation Oven Market : https://www.factmr.com/report/depyrogenation-oven-market
Prophylaxis Pastes Market : https://www.factmr.com/report/prophylaxis-pastes-market
Dental Etching Agents Market: https://www.factmr.com/report/dental-etching-agents-market
Reflective Encoder Market : https://www.factmr.com/report/reflective-encoder-market

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of Fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.